Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor

Type 2 diabetes mellitus is a multifactorial condition characterized by high level of sugar in the blood. To control hyperglycemia, combination therapy is recommended if monotherapy fails to achieve glycemic control. The combination of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a sodium-glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Namyi, Park, Sang-In, Chung, Hyewon, Jin, Xuanyou, Lee, SeungHwan, Kim, Tae-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136081/
https://www.ncbi.nlm.nih.gov/pubmed/32274378
http://dx.doi.org/10.12793/tcp.2020.28.e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136081/
https://www.ncbi.nlm.nih.gov/pubmed/32274378
http://dx.doi.org/10.12793/tcp.2020.28.e4

Ejemplares similares